Pregnancy in the renal transplant recipient

Obstetrics and Gynecology Clinics of North America

Volumn 37, Issue 2, 2010, Pages 211-222

  Josephson, Michelle A ^a   McKay, Dianne B ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SHARP MEMORIAL HOSPITAL   (United States)

Author keywords

Immunosuppression; Kidney transplantation; Pregnancy

Indexed keywords

ATENOLOL; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; DEXAMETHASONE; ERYTHROPOIETIN; HEMOGLOBIN; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; LABETALOL; LEFLUNOMIDE; MERCAPTOPURINE; METHYLDOPA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYOFORTIC; NIFEDIPINE; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT;

ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; BREAST FEEDING; CONGENITAL MALFORMATION; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FERTILITY; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; TERATOGENICITY; TIME; URINARY TRACT INFECTION; ADOLESCENT; ADULT; FEMALE; FEMALE INFERTILITY; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; BREAST FEEDING; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, FEMALE; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; TIME FACTORS;

EID: 79952023888     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2010.02.008     Document Type: Article

References (83)

1. Gill JS, Zalunardo N, Rose C, et al. The pregnancy rate and live birth rate in kidney transplant recipients. Am J Transplant 2009;9(7):1541-9.
2. Fritsche L, Budde K, Dragun D, et al. Testosterone concentrations and sirolimus in male renal transplant patients. Am J Transplant 2004;4(1):130-1.
3. Kaczmarek I, Groetzner J, Adamidis I, et al. Sirolimus impairs gonadal function in heart transplant recipients. Am J Transplant 2004;4(7):1084-8.
4. Tondolo V, Citterio F, Panocchia N, et al. Sirolimus impairs improvement of the gonadal function after renal transplantation. Am J Transplant 2005;5(1):197.
5. Davison JM. Pregnancy in renal allograft recipients: prognosis and management. Baillieres Clin Obstet Gynaecol 1987;1(4):1027-45.
6. McKay DB, Josephson MA, Armenti VT, et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005;5(7):1592-9.
7. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. Nephrol Dial Transplant 2002;17(Suppl 4): 1-67.
8. Kim HW, Seok HJ, Kim TH, et al. The experience of pregnancy after renal transplantation: pregnancies even within postoperative 1 year may be tolerable. Transplantation 2008;85(10):1412-9.
9. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339(10):667-71.
10. Armenti VT, Ahlswede KM, Ahlswede BA, et al. National transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994;57(4):502-6.
11. McKay DB, Josephson MA. Pregnancy in recipients of solid organs-effects on mother and child. N Engl J Med 2006;354(12):1281-93.
12. Radomski JS, Ahlswede BA, Jarrell BE, et al. Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients. Transplant Proc 1995; 27(1):1089-90.
13. National High Blood Pressure Education Program Working Group Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163(5 Pt 1):1691-712.
14. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S1-290.
15. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
16. Pryde PG, Sedman AB, Nugent CE, et al. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993;3(9):1575-82.
17. Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis 2007; 14(2):178-90.
18. Magee LA, Abalos E, von DP, et al. Control of hypertension in pregnancy. Curr Hypertens Rep 2009;11(6):429-36.
19. Umans JG. Medications during pregnancy: antihypertensives and immunosuppressives. Adv Chronic Kidney Dis 2007;14(2):191-8.
20. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med 2009;122(10):890-5.
21. Beitins IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972;81(5):936-45.
22. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977;127(3):264-7.
23. Anderson GG, Rotchell Y, Kaiser DG. Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 1981; 140(6):699-701.
24. Muirhead N, Sabharwal AR, Rieder MJ, et al. The outcome of pregnancy following renal transplantation-the experience of a single center. Transplantation 1992; 54(3):429-32.
25. Penn I, Makowski EL, Harris P. Parenthood following renal transplantation. Kidney Int 1980;18(2):221-33.
26. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973;115(8):1100-6.
27. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985;92(3):233-9.
28. Githens JH, Rosenkrantz JG, Tunnock SM. Teratogenic effects of azathioprine (imuran). J Pediatr 1965;66:959-61.
29. Rosenkrantz JG, Githens JH, Cox SM, et al. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol 1967;97(3):387-94.
30. Tallent MB, Simmons RL, Najarian JS. Birth defects in child of male recipient of kidney transplant. JAMA 1970;211(11):1854-5.
31. Williamson RA, Karp LE. Azathioprine teratogenicity: review of the literature and case report. Obstet Gynecol 1981;58(2):247-50.
32. Pickrell MD, Sawers R, Michael J. Pregnancy after renal transplantation: severe intrauterine growth retardation during treatment with cyclosporin A. Br Med J (Clin Res Ed) 1988;296(6625):825.
33. Kainz A, Harabacz I, Cowlrick IS, et al. Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus. Transpl Int 2000;13(Suppl 1): S299-300.
34. Armenti VT, Moritz MJ, Cardonick EH, et al. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs 2002;62(16):2361-75.
35. Hou S. Pregnancy in renal transplant recipients. Adv Ren Replace Ther 2003; 10(1):40-7.
36. Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64(4):559-65.
37. Brent RL. Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001;63(2):106-12.
38. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30(2):241-6.
39. Pergola PE, Kancharla A, Riley DJ. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation 2001;71(7):994-7.
40. Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006;82(12):1698-702.
41. Anderka MT, Lin AE, Abuelo DN, et al. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 2009;149(6):1241-8.
42. Dei Malatesta MF, Rocca B, Gentile T, et al. A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. Transplant Proc 2009;41(4):1407-9.
43. Merlob P, Stahl B, Klinger G. Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol 2009;28(1):105-8.
44. Mycophenolae mofetil [package insert]. Nutley (NJ): Roche Laboratories; 2007.
45. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002;17(2):121-30.
46. Chu SH, Liu KL, Chiang YJ, et al. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc 2008;40(7): 2446-8.
47. Thomas AG, Burrows L, Knight R, et al. The effect of pregnancy on cyclosporine levels in renal allograft patients. Obstet Gynecol 1997;90(6):916-9.
48. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50(2):222-39.
49. Jain AB, Shapiro R, Scantlebury VP, et al. Pregnancy after kidney and kidneypancreas transplantation under tacrolimus: a single center's experience. Transplantation 2004;77(6):897-902.
50. Armenti VT, Ahlswede KM, Ahlswede BA, et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995;59(4):476-9.
51. Davison JM, Lindheimer MD. Pregnancy in renal transplant recipients. J Reprod Med 1982;27(10):613-21.
52. Aluvihare VR, Kallikourdis M, Betz AG. Tolerance, suppression and the fetal allograft. J Mol Med 2005;83(2):88-96.
53. Streilein JW. Peripheral tolerance induction: lessons from immune privileged sites and tissues. Transplant Proc 1996;28(4):2066-70.
54. Lindheimer MD, Katz AI. The normal and diseased kidney in pregnancy. In: Schrier R, editor. Diseases of the kidney. 7th edition. Philadelphia: Lippincott, Williams, Wilkins; 2001. p. 2129-65.
55. Nicolle LE. Asymptomatic bacteriuria: when to screen and when to treat. Infect Dis Clin North Am 2003;17(2):367-94.
56. Pedler SJ, Orr KE. Bacterial, fungal, and parasitic infections. In: Barron WM, Lindheimer MD, editors. Medical disorders during pregnancy. 3 edition. St. Louis (MO): Mosby; 2000. p. 411.
57. Magee LA, von DP, Darley J, et al. Erythropoiesis and renal transplant pregnancy. Clin Transplant 2000;14(2):127-35.
58. Goshorn J, Youell TD. Darbepoetin alfa treatment for post-renal transplantation anemia during pregnancy. Am J Kidney Dis 2005;46(5):e81-6.
59. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2003131-41.
60. Stratta P, Canavese C, Giacchino F, et al. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol 2003;16(6):792-806.
61. Morales JM, Hernandez PG, Andres A, et al. Uric acid handling, pregnancy and cyclosporin in renal transplant women. Nephron 1990;56(1):97-8.
62. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16(2):206-15.
63. Irgens HU, Reisaeter L, Irgens LM, et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323(7323):1213-7.
64. Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004;89(12):6239-43.
65. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008;359(8):800-9.
66. Villar J, Abalos E, Nardin JM, et al. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 2004;24(6):607-15.
67. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006;194(3):639-49.
68. Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367(9517):1145-54.
69. Lindheimer MD, Sibai BM. Antioxidant supplementation in pre-eclampsia. Lancet 2006;367(9517):1119-20.
70. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7):672-83.
71. Hladunewich MA, Steinberg G, Ananth KS, et al. Angiogenic factor abnormalities and fetal demise in a twin pregnancy. Nat Rev Nephrol 2009;5(11):658-62.
72. McKay DB, Adams PL, Bumgardner GL, et al. Reproduction and pregnancy in the transplanted patient: current practices. Prog Transplant 2006;16(2):127-32.
73. Grimer M. The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors. Nephrology (Carlton) 2007; 12(Suppl 1):S98-105.
74. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93(1):137-50.
75. Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int 1985;27(1):74-9.
76. First MR, Combs CA, Weiskittel P, et al. Lack of effect of pregnancy on renal allograft survival or function. Transplantation 1995;59(4):472-6.
77. Sturgiss SN, Davison JM. Effect of pregnancy on the long-term function of renal allografts: an update. Am J Kidney Dis 1995;26(1):54-6.
78. Tanabe K, Kobayashi C, Takahashi K, et al. Long-term renal function after pregnancy in renal transplant recipients. Transplant Proc 1997;29(1-2):1567-8.
79. Salmela KT, Kyllonen LE, Holmberg C, et al. Impaired renal function after pregnancy in renal transplant recipients. Transplantation 1993;56(6):1372-5.
80. Levidiotis V, Chang S, McDonald S. Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol 2009;20(11):2433-40.
81. Ibrahim HN, Akkina SK, Leister E, et al. Pregnancy outcomes after kidney donation. Am J Transplant 2009;9(4):825-34.
82. Josephson MA. Transplantation: pregnancy after kidney donation: more questions than answers. Nat Rev Nephrol 2009;5(9):495-7.
83. Reisaeter AV, Roislien J, Henriksen T, et al. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant 2009;9(4):820-4.